Baupost Group - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baupost Group ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$5,032,000
-61.1%
4,337,858
-43.6%
0.14%
-61.2%
Q3 2013$12,922,000
-16.0%
7,691,4530.0%0.37%
-3.4%
Q2 2013$15,383,0007,691,4530.38%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Baupost Group 4,337,858$5,032,0000.14%
PRICE MICHAEL F 748,200$868,0000.11%
ALGERT GLOBAL LLC 124,891$145,0000.04%
Rotella Capital Management, Inc. 13,701$16,0000.03%
Icahn Capital 5,904,863$6,850,0000.02%
Spark Investment Management LLC 110,100$127,0000.02%
FCG ADVISORS, LLC 20,000$23,0000.02%
BRANDES INVESTMENT PARTNERS, LP 1,023,893$1,188,0000.02%
GLOBEFLEX CAPITAL L P 101,454$117,0000.01%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 129,089$149,0000.01%
View complete list of ENZON PHARMACEUTICALS INC shareholders